Bentham Science Logo

Track Your Manuscript:


Current Cancer Drug Targets

Volume 22, 11 Issues, 2022
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access

Forthcoming Thematic Issues

Targeting Receptor Tyrosine Kinases (RTKs) using Novel Cancer Therapeutics
Guest Editor(s): Abdulhameed (Abdul) Al-Ghabkari, Hellen Kusane

Submit Abstract via Email Download Description
Cancer Exosomes – Prognostic Significance and their Utilization as Novel Drug Delivery System for Circumvention of Cancer Drug Resistance
Guest Editor(s): Kenneth Kin Wah To

Submit Abstract via Email Download Description

Editor-in-Chief

Ruiwen Zhang
Center for Drug Discovery
University of Houston
Houston, TX
(USA)
Biography
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Cancer Drug Targets was launched in 2001. Dr. Ruiwen Zhang serves as the Editor-in-Chief of the journal.

Advertisement

Mechanisms-of-Metabolic-Disorders-(MMD)

Related Journals

Related eBooks

eBooks Catalog